• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza vaccine effectiveness among high-risk groups: a systematic literature review and meta-analysis of case-control and cohort studies

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2017 May 8:0. doi: 10.1080/21645515.2017.1321722. [Epub ahead of print]
[h=1]Influenza vaccine effectiveness among high-risk groups: a systematic literature review and meta-analysis of case-control and cohort studies.[/h] Restivo V[SUP]1[/SUP], Costantino C[SUP]1[/SUP], Bono S[SUP]1[/SUP], Maniglia M[SUP]1[/SUP], Marchese V[SUP]1[/SUP], Ventura G[SUP]1[/SUP], Casuccio A[SUP]1[/SUP], Tramuto F[SUP]1[/SUP], Vitale F[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Vaccination represents the most effective intervention to prevent infection, hospitalization and mortality due to influenza. This meta-analysis quantifies data reporting influenza vaccine effectiveness (VE) on influenza visits and hospitalizations of case-control and cohort studies among high-risk groups. A systematic literature review including original articles published between 2007 and 2016, using a protocol registered on Prospero with No. 42017054854, and a meta-analysis were conducted. For three high-risk groups (subjects with underlying health conditions, pregnant women and health care workers) only a qualitative evaluation was carried out. The VE quantitative analysis demonstrated a clear significant overall effect of 39% (95%CI: 32%-46%) for visits and 57% (95%CI: 30%-74%) for hospitalization among children. Considering the elderly influenza VE had a clear effect of 25% (95%CI: 6%-40%) for visits and 14% (95%CI: 7%-21%; p<0.001) for hospitalization. This study showed the high VE of influenza vaccination among high-risk groups, representing a tool for public health decision-makers to develop evidence-based preventive interventions to avoid influenza outcomes.


[h=4]KEYWORDS:[/h] ALRI = influenza-associated acute lower respiratory infections; GP = general practitioner; HCW = Health Care Worker; ILI = influenza-like illness; Influenza; OR = Odds ratio; RR = Relative risk; SLR = systematic literature review; SOT = solid organ transplant; VE = vaccine effectiveness; WHO = World Health Organization; children; chronic disease; effectiveness; elderly subjects; health care worker; hospitalization; pregnancy; vaccine; visit

PMID: 28481673 DOI: 10.1080/21645515.2017.1321722
 
Back
Top Bottom